Last modified: September 25, 2024
Home
NewsPRESS RELEASE(Bilateral Discussion on Implementation of the Agreement signed for recognition of official control exercised by BFDA and FSSAI, India)
PRESS RELEASE(Bilateral Discussion on Implementation of the Agreement signed for recognition of official control exercised by BFDA and FSSAI, India)
Recent Posts
- Competency Examination on 05 May, 2026
- Notification-Revised Market Authorization Guidelines.
- Regulatory Notification on Publication of Irrational FDC
- Regulatory Notification on publication of Bioequivalence and Biowaiver list
- Public Consultation on “Guideline for Post-market and market surveillance of medical device:Management of adverse events”
Recent Posts
-
Competency Examination on 05 May, 2026
March 23, 2026
-
Notification-Revised Market Authorization Guidelines.
March 17, 2026
-
Regulatory Notification on Publication of Irrational FDC
March 16, 2026
Bhutan Food and Drug Authority
- Ministry of Health,
- Kawajangsa,
- Tashichhodzong, Thimphu
- Toll Free No: 1555
- Post box : 1071
- Email: bfdahq@bfda.gov.bt
Disclaimer: Subject to change; verify with authorities.
Copyright © 2025 - BFDA\Developed by WONS